Deutsche Bank’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
CL
FPCG
Deutsche Bank's LPCN Position: Q1 2020 in Review
Deutsche Bank sold out of Lipocine (LPCN) in Q1 2020, closing a stake of 3,468 shares — an estimated $22K sold.
Deutsche Bank first reported a position in LPCN in Q4 2014 and held it in 18 quarters. The position peaked at $606K in Q3 2017. 28 funds tracked by Wall St. Rank hold LPCN as of Q1 2020.
- Deutsche Bank reported no remaining Lipocine position as of Q1 2020 after selling out during the quarter.
- Deutsche Bank sold 3,468 Lipocine shares in Q1 2020, an estimated $22K.
- Deutsche Bank first reported a position in Lipocine in Q4 2014 and held it in 18 quarters.
- Deutsche Bank's Lipocine position peaked at $606K in Q3 2017.
- 28 funds tracked by Wall St. Rank held Lipocine as of Q1 2020.
Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.